Medicare-PartD.com announces online money-saving services
SAINT AUGUSTINE, Fla. Medicare beneficiaries and others have a new way to find discounted prescription drugs at retailers.
The Web site Medicare-PartD.com announced the release of RxSavings-Center service Wednesday. The service allows users to search for drugs alphabetically by drug name or usage category or by browsing a list of medications available through retail discount drug programs. People can also use RxSavings-Finder, a search engine, to compare up to four retail discount programs across three usage categories at once.
“We designed the RxSavings-Center in direct response to the requests of our online community, which includes many Medicare beneficiaries who are entering the coverage gap or ‘donute hole’ portion of their Medicare Part D prescription drug plans,” said Susan Johnson, who leads technical development of the Medicare-PartD Web site.
King’s $1.4 billion bid rejected by Alpharma
NEW YORK King Pharmaceuticals would gain access to a transdermal patch to treat pain if it acquired Alpharma.
So far, however, Alpharma isn’t interested in King’s $1.4 billion cash offer to acquire the company and its NSAID patch Flector and the Kadian extended-release morphine product, saying in a written statement that King’s three bids for the company since July have undervalued the company.
“We are willing to entertain a proposal from you that we believe more appropriately values the company,” Alpharma chief executive officer Dean Mitchell wrote in a letter to King chief executive officer Brian Markison. “To that end, we remain open to discussions with you at a price that we believe reflects the inherent value of Alpharma.”
LDL cholesterol levels linked to cancers in diabetics
NEW YORK LDL cholesterol has been linked to higher risk of cancer in patients with Type 2 diabetes, according to a study.
The study, conducted by researchers in Hong Kong, examined 6,107 patients with diabetes, none of whom took statins to lower cholesterol. It found that patients with LDL cholesterol levels less than 2.8 millimoles per liter of blood had higher risk of cancers in the digestive, reproductive, lymphatic and circulatory systems. Meanwhile, patients with levels greater than 3.8 millimoles had more risk of oral, bone, skin, breast and connective tissue cancers.
The researchers published their study in the Canadian Medical Association Journal.